# Icon Plc (ICLR)

Source page: https://stoqly.net/companies/iclr

- **Ticker:** ICLR (Nasdaq)
- **Sector:** Health Care / Services-Commercial Physical & Biological Research
- **SEC CIK:** 0001060955
- **Latest annual report:** 20-F filed 2026-05-27 (https://www.sec.gov/Archives/edgar/data/1060955/000162828026038487/iclr-20251231.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $211.36 on 2026-10-30
- **Market cap:** $16.4B
- **P/E (trailing):** 35.8x
- **EPS, trailing 12 months:** $5.90
- **Revenue (FY2025):** $8.3B
- **Revenue growth:** +0.8%
- **Revenue growth, 5-year CAGR:** +24.2%
- **Operating margin:** 5.4%
- **Net margin:** 2.8%
- **Free cash flow:** $862M
- **Free cash flow margin:** 10.4%
- **Return on invested capital:** 3.5%
- **Return on equity:** 2.5%
- **Net debt:** $2.2B
- **Net debt / EBITDA:** 2.7x
- **Change in share count:** −4.9%
- **Piotroski F-score:** 6/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/iclr/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 1,666 | 1,758 | 2,596 | 2,806 | 2,797 | 5,481 | 7,741 | 8,055 | 8,189 | 8,251 |
| Operating income | 312 | 338 | 373 | 433 | 392 | 379 | 795 | 905 | 1,032 | 443 |
| Net income | 262 | 281 | 323 | 374 | 332 | 153 | 505 | 554 | 739 | 229 |
| Diluted EPS (US$) | 4.65 | 5.13 | 5.89 | 6.79 | 6.15 | 2.25 | 6.13 | 6.70 | 8.90 | 2.90 |
| Operating cash flow | 259 | 383 | 269 | 413 | 568 | 829 | 563 | 1,161 | 1,287 | 1,036 |
| Free cash flow | 217 | 338 | 220 | 374 | 527 | 735 | 421 | 1,020 | 1,119 | 862 |
| Cash | 261 | 360 | 456 | 570 | 842 | 754 | 290 | 380 | 539 | 647 |
| Debt and leases | — | — | — | — | 348 | 5,501 | 4,701 | 3,806 | 3,396 | 2,873 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.